Avinger, Inc. (NASDAQ:AVGR) Sees Significant Increase in Short Interest

Avinger, Inc. (NASDAQ:AVGR) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 234,700 shares, an increase of 301.9% from the December 31st total of 58,400 shares. Based on an average daily trading volume, of 1,990,000 shares, the short-interest ratio is currently 0.1 days. Approximately 8.5% of the shares of the company are sold short.

Avinger Price Performance

NASDAQ:AVGR traded down $0.02 during mid-day trading on Tuesday, hitting $0.55. The company’s stock had a trading volume of 73,938 shares, compared to its average volume of 916,690. Avinger has a 1 year low of $0.39 and a 1 year high of $5.45. The stock has a market cap of $1.82 million, a price-to-earnings ratio of -0.05 and a beta of 1.15. The business’s fifty day moving average is $0.75 and its two-hundred day moving average is $0.98.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.82) EPS for the quarter, beating the consensus estimate of ($2.03) by $0.21. The company had revenue of $1.65 million for the quarter, compared to analyst estimates of $1.60 million. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. During the same period last year, the company earned ($2.92) earnings per share. Analysts anticipate that Avinger will post -4.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Avinger in a report on Tuesday, January 21st. They set a “hold” rating for the company.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.